--- title: "Beyond Air, Inc. (XAIR.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/XAIR.US.md" symbol: "XAIR.US" name: "Beyond Air, Inc." industry: "Health Care Equipment" datetime: "2026-03-12T14:44:51.095Z" locales: - [en](https://longbridge.com/en/quote/XAIR.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/XAIR.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/XAIR.US.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/XAIR.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/XAIR.US.md) # Beyond Air, Inc. (XAIR.US) ## Company Overview Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Exchange | US Market | | Website | [www.beyondair.net](https://www.beyondair.net) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: D > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-03-12T04:30:15.000Z **Overall: D (0.60)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 147 / 188 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: D #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 129.04% | | | Net Profit YoY | 40.72% | | | P/B Ratio | 1.04 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 8458222.04 | | | Revenue | 6924000.00 | | #### Multi Score Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -240.74% | E | | Profit Margin | -447.73% | E | | Gross Margin | 13.67% | D | | Revenue YoY | 129.04% | A | | Net Profit YoY | 40.72% | B | | Total Assets YoY | 7.70% | B | | Net Assets YoY | -54.92% | E | | Cash Flow Margin | -22.33% | D | | OCF YoY | 129.04% | A | | Turnover | 0.20 | D | | Gearing Ratio | 77.47% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Beyond Air, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "129.04%", "rating": "" }, { "name": "Net Profit YoY", "value": "40.72%", "rating": "" }, { "name": "P/B Ratio", "value": "1.04", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "8458222.04", "rating": "" }, { "name": "Revenue", "value": "6924000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "D", "indicators": [ { "name": "ROE", "value": "-240.74%", "rating": "E" }, { "name": "Profit Margin", "value": "-447.73%", "rating": "E" }, { "name": "Gross Margin", "value": "13.67%", "rating": "D" }, { "name": "Revenue YoY", "value": "129.04%", "rating": "A" }, { "name": "Net Profit YoY", "value": "40.72%", "rating": "B" }, { "name": "Total Assets YoY", "value": "7.70%", "rating": "B" }, { "name": "Net Assets YoY", "value": "-54.92%", "rating": "E" }, { "name": "Cash Flow Margin", "value": "-22.33%", "rating": "D" }, { "name": "OCF YoY", "value": "129.04%", "rating": "A" }, { "name": "Turnover", "value": "0.20", "rating": "D" }, { "name": "Gearing Ratio", "value": "77.47%", "rating": "E" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.27 | 65/188 | - | - | - | | PB | 1.04 | 30/188 | 1.30 | 1.12 | 0.89 | | PS (TTM) | 1.22 | 33/188 | 5.43 | 2.90 | 1.81 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Delcath (DCTH.US) | C | A | B | A | A | A | | 02 | Abbott Laboratories (ABT.US) | B | C | C | C | C | B | | 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B | | 04 | Stryker (SYK.US) | A | B | B | C | B | B | | 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-03-11T04:00:00.000Z Total Analysts: **4** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 2 | 50% | | Overweight | 1 | 25% | | Hold | 1 | 25% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 0.81 | | Highest Target | 14.00 | | Lowest Target | 2.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/XAIR.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/XAIR.US/norm.md) - [Related News](https://longbridge.com/en/quote/XAIR.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/XAIR.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**